1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands

The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.

Saved in:
Bibliographic Details
Main Author BERNOTAS RONALD C.,LENICEK STEVEN E.,ANTANE SCHUYLER A
Format Patent
LanguageEnglish
Published 16.05.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
Bibliography:Application Number: CN20038012872